FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-664 | 70004-664-46 | Heparin Sodium | 7500 [USP'U] | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-303 | 70004-303-16 | Hydromorphone Hydrochloride | 1 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-303 | 70004-303-22 | Hydromorphone Hydrochloride | 1 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-302 | 70004-302-22 | Hydromorphone Hydrochloride | .5 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-300 | 70004-300-21 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-300 | 70004-300-22 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-300 | 70004-300-18 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-300 | 70004-300-63 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-303 | 70004-303-21 | Hydromorphone Hydrochloride | 1 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-300 | 70004-300-16 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-300 | 70004-300-62 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-303 | 70004-303-17 | Hydromorphone Hydrochloride | 1 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-695 | 70004-695-31 | Isoproterenol Hydrochloride | .004 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-695 | 70004-695-33 | Isoproterenol Hydrochloride | .004 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-433 | 70004-433-05 | Ketamine Hydrochloride | 50 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-434 | 70004-434-30 | Ketamine Hydrochloride | 2 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-430 | 70004-430-12 | Ketamine Hydrochloride | 10 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-430 | 70004-430-09 | Ketamine Hydrochloride | 10 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-700 | 70004-700-06 | Labetalol Hydrochloride | 5 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-700 | 70004-700-28 | Labetalol Hydrochloride | 5 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-728 | 70004-728-12 | Lidocaine Hydrochloride | 20 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-720 | 70004-720-12 | Lidocaine Hydrochloride | 10 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-720 | 70004-720-09 | Lidocaine Hydrochloride | 10 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-720 | 70004-720-05 | Lidocaine Hydrochloride | 10 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-723 | 70004-723-09 | Lidocaine Hydrochloride | 20 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-725 | 70004-725-09 | Lidocaine Hydrochloride Anhydrous | 10 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-725 | 70004-725-05 | Lidocaine Hydrochloride Anhydrous | 10 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-725 | 70004-725-12 | Lidocaine Hydrochloride Anhydrous | 10 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "Sincerus Florida, LLC(080105003)" | Salicylic Acid; Ciclopirox | 20 g/100 mL; .77 g/100 mL | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "Sincerus Florida, LLC(080105003)" | Salicylic Acid; Ciclopirox | 20 g/100 mL; .77 g/100 mL | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "Sincerus Florida, LLC(080105003)" | Salicylic Acid; Ciclopirox; Clobetasol Propionate | 30 g/100 mL; .77 g/100 mL; .05 g/100 mL | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "Sincerus Florida, LLC(080105003)" | Salicylic Acid; Ciclopirox; Clobetasol Propionate | 30 g/100 mL; .77 g/100 mL; .05 g/100 mL | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "Sincerus Florida, LLC(080105003)" | Levocetirizine Dihydrochloride; Clobetasol Propionate | 20 g/100 mL; .05 g/100 mL | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "Sincerus Florida, LLC(080105003)" | Levocetirizine Dihydrochloride; Clobetasol Propionate | 20 g/100 mL; .05 g/100 mL | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "Sincerus Florida, LLC(080105003)" | Lidocaine; Dibucaine Hydrochloride; Phenylephrine Hydrochloride; Prilocaine | 15 g/100 mL; .5 g/100 mL; 10 g/100 mL; 50 g/100 mL | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "Sincerus Florida, LLC(080105003)" | Lidocaine; Dibucaine Hydrochloride; Phenylephrine Hydrochloride; Prilocaine | 15 g/100 mL; .5 g/100 mL; 10 g/100 mL; 50 g/100 mL | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "US Compounding, Inc.(607517146)" | Magnesium Hydroxide; Aluminum Hydroxide; Dimethicone; Lidocaine Hydrochloride | 1.2 g/1 mL; 1.2 g/1 mL; .12 g/1 mL; 2 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "US Compounding, Inc.(607517146)" | 62295-3119 | 62295-3119-1 | Methylprednisolone Acetate | 80 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "US Compounding, Inc.(607517146)" | 62295-3122 | 62295-3122-7 | Methylprednisolone Acetate; Lidocaine Hydrochloride | 80 mg/1 mL; 10 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "US Compounding, Inc.(607517146)" | 62295-3121 | 62295-3121-7 | Methylprednisolone Acetate; Lidocaine Hydrochloride | 40 mg/1 mL; 10 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "US Compounding, Inc.(607517146)" | 62295-3324 | 62295-3324-5 | Neostigmine Methylsulfate | 1 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "US Compounding, Inc.(607517146)" | Ondansetron Hydrochloride | 8 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "US Compounding, Inc.(607517146)" | 62295-3322 | 62295-3322-7 | Phenylephrine Hydrochloride | 1 mg/10 mL | 2019-2 | valid | 2026-11-14 | ||
| "US Compounding, Inc.(607517146)" | Polyethylene Glycol 3350 | 1 g/1 g | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "US Compounding, Inc.(607517146)" | Polyethylene Glycol 3350 | 1 g/1 g | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "US Compounding, Inc.(607517146)" | 62295-3284 | 62295-3284-7 | Betamethasone Sodium Phosphate; Betamethasone Acetate | 4 mg/1 mL; 3 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "US Compounding, Inc.(607517146)" | 62295-5027 | 62295-5027-1 | Promethazine Hydrochloride | 25 mg/1 g | 2019-2 | valid | 2026-11-14 | ||
| "US Compounding, Inc.(607517146)" | 62295-5071 | 62295-5071-6 | Sodium Hydroxide | 100 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "US Compounding, Inc.(607517146)" | 62295-3323 | 62295-3323-7 | Succinylcholine Chloride | 20 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "US Compounding, Inc.(607517146)" | 62295-2169 | 62295-2169-6 | Testosterone Propionate; Testosterone Cypionate | 20 mg/1 mL; 200 mg/1 mL | 2019-2 | valid | 2026-11-14 |